Last reviewed · How we verify
Oral Sildenafil 50 mg
At a glance
| Generic name | Oral Sildenafil 50 mg |
|---|---|
| Also known as | Accel-Sildenafil - 50 mg, sildanafil, Viagra 50 mg film coated tablets, Revatio, Sildenafil |
| Sponsor | Strategic Science & Technologies, LLC |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- A New Sildenafil Oral Film in Patients With Erectile Dysfunction (PHASE3)
- Oral Sildenafil Citrate to Improve Maternal and Neonatal Outcomes in Low-resource Settings (PHASE3)
- Intrapartum Sildenafil in Laboring Mothers (PHASE3)
- The Phosphodiesterase 5 Inhibitor Sildenafil as an Adjunct to Antidepressants in Major Depressive Disorder Patients (NA)
- Sorafenib, Valproic Acid, and Sildenafil in Treating Patients With Recurrent High-Grade Glioma (PHASE2)
- Cerebrovascular Reactivity Assessed With fNIRS as a Biomarker of TCVI After Acute Traumatic Brain Injury in Military (PHASE2)
- Effect of Oral Sildenafil Citrate on Improvement of Endometrial Thickness (PHASE2, PHASE3)
- Effect of Sildenafil Citrate Compared to Estrogen as Adjuvant Therapy for Unexplained Infertility (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Oral Sildenafil 50 mg CI brief — competitive landscape report
- Oral Sildenafil 50 mg updates RSS · CI watch RSS
- Strategic Science & Technologies, LLC portfolio CI